Clinical Trial Update: Evaluation of the Effect of Different Doses Dexmedetomidine Infusion on Lung Mechanics and Oxygenation in Obese Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating different dexmedetomidine infusion doses on lung mechanics and oxygenation in obese patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: National Cancer Institute, Egypt | Conditions: Obesity; Drug | Phase 2 | Status: COMPLETED